The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2022 | A comparison of imaging techniques in multiple myeloma
In this video, Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, compares two techniques routinely used for imaging patients with multiple myeloma: PET-CT and MRI. Dr Zamagni notes the prognostic role of both techniques prior to and after therapy, and that currently MRI seems more sensitive; however, this higher sensitivity might not translate into clinical significance when used post-therapy. A prospective comparison of the two techniques is currently ongoing. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
Disclosures
Honoraria and advisory board member for Janssen, Sanofi, BMS, Roche, Amgen, GSK, Pfizer
